Last update 15 Apr 2025

SYD-1875

Overview

Basic Info

Drug Type
Antibody drug conjugate (ADC)
Synonyms
Anti-5T4 antibody drug conjugate, SYD 1875
Target
5T4 x DNA
Action
inhibitors
Mechanism
5T4 inhibitors(Trophoblast glycoprotein inhibitors), DNA inhibitors(DNA inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Solid tumor
Inactive Indication-
Originator Organization
Synthon BVSynthon BV
Active Organization
Byondis BVByondis BV
Inactive Organization
Synthon BVSynthon BV
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

1
Clinical Trials associated with SYD-1875
NCT04202705
/ CompletedPhase 1
A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate SYD1875 to Evaluate the Safety, Pharmacokinetics and Efficacy in Patients With 5T4-expressing Locally Advanced or Metastatic Solid Tumours
100 Clinical Results associated with SYD-1875
Login to view more data
100 Translational Medicine associated with SYD-1875
Login to view more data
100 Patents (Medical) associated with SYD-1875
Login to view more data
100 Deals associated with SYD-1875
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Solid tumorPhase 1
Belgium
Byondis BVByondis BV
28 Feb 2020
Solid tumorPhase 1
Belgium
Synthon BVSynthon BV
28 Feb 2020
Solid tumorPhase 1
France
Synthon BVSynthon BV
28 Feb 2020
Solid tumorPhase 1
France
Byondis BVByondis BV
28 Feb 2020
NeoplasmsDiscovery
Netherlands
Synthon BVSynthon BV
28 Feb 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free